109 related articles for article (PubMed ID: 9051381)
41. Hyperglycemia as a major determinant of distal polyneuropathy independent of age and diabetes duration in patients with recently diagnosed diabetes.
Matsumoto T; Ohashi Y; Yamada N; Kikuchi M
Diabetes Res Clin Pract; 1994 Dec; 26(2):109-13. PubMed ID: 7705191
[TBL] [Abstract][Full Text] [Related]
42. Cigarette smoking and neuropathy in diabetic patients.
Mitchell BD; Hawthorne VM; Vinik AI
Diabetes Care; 1990 Apr; 13(4):434-7. PubMed ID: 2318103
[TBL] [Abstract][Full Text] [Related]
43. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM.
Nelson RG; Knowler WC; Pettitt DJ; Hanson RL; Bennett PH
Diabetes Care; 1995 Feb; 18(2):182-7. PubMed ID: 7729295
[TBL] [Abstract][Full Text] [Related]
44. Exercise in the management of non-insulin-dependent diabetes mellitus.
Wallberg-Henriksson H; Rincon J; Zierath JR
Sports Med; 1998 Jan; 25(1):25-35. PubMed ID: 9458525
[TBL] [Abstract][Full Text] [Related]
45. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study.
Davis TM; Yeap BB; Davis WA; Bruce DG
Diabetologia; 2008 Apr; 51(4):562-6. PubMed ID: 18193189
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.
Hanefeld M; Fischer S; Julius U; Schulze J; Schwanebeck U; Schmechel H; Ziegelasch HJ; Lindner J
Diabetologia; 1996 Dec; 39(12):1577-83. PubMed ID: 8960845
[TBL] [Abstract][Full Text] [Related]
47. [Association between neuropathy and peripheral vascular insufficiency in patients with diabetes mellitus type 2].
Millán-Guerrero RO; Vásquez C; Isaís-Millán S; Trujillo-Hernández B; Caballero-Hoyos R
Rev Invest Clin; 2011; 63(6):621-9. PubMed ID: 23650675
[TBL] [Abstract][Full Text] [Related]
48. The prevalence, clinical features and management of periphral neuropathy among diabetic patients in Tikur Anbessa and St. Paul's Specialized University Hospitals, Addis Ababa, Ethiopia.
Jarso G; Ahmed A; Feleke Y
Ethiop Med J; 2011 Oct; 49(4):299-311. PubMed ID: 23409395
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects.
Lehtinen JM; Uusitupa M; Siitonen O; Pyörälä K
Diabetes; 1989 Oct; 38(10):1307-13. PubMed ID: 2551761
[TBL] [Abstract][Full Text] [Related]
50. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
[TBL] [Abstract][Full Text] [Related]
51. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
[TBL] [Abstract][Full Text] [Related]
52. Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older.
Tierney EF; Thurman DJ; Beckles GL; Cadwell BL
J Diabetes; 2013 Jun; 5(2):207-15. PubMed ID: 23121724
[TBL] [Abstract][Full Text] [Related]
53. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
[TBL] [Abstract][Full Text] [Related]
54. Standardizing corneal nerve fibre length for nerve tortuosity increases its association with measures of diabetic neuropathy.
Edwards K; Pritchard N; Vagenas D; Russell A; Malik RA; Efron N
Diabet Med; 2014 Oct; 31(10):1205-9. PubMed ID: 24750318
[TBL] [Abstract][Full Text] [Related]
55. Effect of risk factors on exercise capacity in NIDDM.
Estacio RO; Wolfel EE; Regensteiner JG; Jeffers B; Havranek EP; Savage S; Schrier RW
Diabetes; 1996 Jan; 45(1):79-85. PubMed ID: 8522064
[TBL] [Abstract][Full Text] [Related]
56. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study.
Hamman RF; Marshall JA; Baxter J; Kahn LB; Mayer EJ; Orleans M; Murphy JR; Lezotte DC
Am J Epidemiol; 1989 Feb; 129(2):295-311. PubMed ID: 2912042
[TBL] [Abstract][Full Text] [Related]
57. The role of dietary fiber in the etiology of non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study.
Marshall JA; Weiss NS; Hamman RF
Ann Epidemiol; 1993 Jan; 3(1):18-26. PubMed ID: 8287151
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study.
Rewers M; Shetterly SM; Baxter J; Marshall JA; Hamman RF
Am J Epidemiol; 1992 Jun; 135(12):1321-30. PubMed ID: 1510079
[TBL] [Abstract][Full Text] [Related]
59. Neuropathy in non-insulin-dependent diabetes mellitus. The significance of symptoms.
Hong CY; Chia SE; Fong SK
Scand J Prim Health Care; 1998 Dec; 16(4):233-7. PubMed ID: 9932317
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of asymptomatic bacteriuria in subjects with NIDDM in San Luis Valley of Colorado.
Keane EM; Boyko EJ; Reller LB; Hamman RF
Diabetes Care; 1988 Oct; 11(9):708-12. PubMed ID: 3224541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
